Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Data from the double-blind, international Phase III ENSURE trial showed that 100 ug corifollitropin
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury